Identification of a novel cuproptosis-related gene signature for multiple myeloma diagnosis

被引:3
|
作者
Zhu, Yidong [1 ]
Chang, Shuaikang [2 ]
Liu, Jun [1 ]
Wang, Bo [3 ]
机构
[1] Tongji Univ, Shanghai Peoples Hosp 10, Sch Med, Dept Tradit Chinese Med, Shanghai, Peoples R China
[2] Tongji Univ, Sch Med, Dept Hematol, Shanghai East Hosp, Shanghai, Peoples R China
[3] Tongji Univ, Yangpu Hosp, Sch Med, Dept Endocrinol, Shanghai, Peoples R China
关键词
biomarker; cuproptosis; LASSO; multiple myeloma; SVM-RFE; tumor immunity; REGULATORY T-CELLS; HUMAN PYRUVATE-DEHYDROGENASE; MAST-CELLS; STRUCTURAL BASIS; COPPER; PHOSPHORYLATION; DENSITY; DEPOSITION; P14(ARF); COMPLEX;
D O I
10.1002/iid3.1058
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
BackgroundMultiple myeloma (MM) ranks second among the most prevalent hematological malignancies. Recent studies have unearthed the promise of cuproptosis as a novel therapeutic intervention for cancer. However, no research has unveiled the particular roles of cuproptosis-related genes (CRGs) in the prediction of MM diagnosis.MethodsMicroarray data and clinical characteristics of MM patients were obtained from the Gene Expression Omnibus (GEO) database. Differentially expressed gene analysis, least absolute shrinkage and selection operator (LASSO) and support vector machine-recursive feature elimination (SVM-RFE) algorithms were applied to identify potential signature genes for MM diagnosis. Predictive performance was further assessed by receiver operating characteristic (ROC) curves, nomogram analysis, and external data sets. Functional enrichment analysis was performed to elucidate the involved mechanisms. Finally, the expression of the identified genes was validated by quantitative real-time polymerase chain reaction (qRT-PCR) in MM cell samples.ResultsThe optimal gene signature was identified using LASSO and SVM-RFE algorithms based on the differentially expressed CRGs: ATP7A, FDX1, PDHA1, PDHB, MTF1, CDKN2A, and DLST. Our gene signature-based nomogram revealed a high degree of accuracy in predicting MM diagnosis. ROC curves showed the signature had dependable predictive ability across all data sets, with area under the curve values exceeding 0.80. Additionally, functional enrichment analysis suggested significant associations between the signature genes and immune-related pathways. The expression of the genes was validated in MM cells, indicating the robustness of these findings.ConclusionWe discovered and validated a novel CRG signature with strong predictive capability for diagnosing MM, potentially implicated in MM pathogenesis and progression through immune-related pathways. We identified a novel signature associated with cuproptosis-related genes, which exhibited a strong diagnostic value for multiple myeloma (MM). Our study highlights the involvement of cuproptosis-related genes in the diagnosis of MM and investigates the underlying molecular mechanisms, offering novel insights into the pathogenesis and progression of MM.image
引用
收藏
页数:15
相关论文
共 50 条
  • [31] Identification and validation of a novel cuproptosis-related lncRNA gene signature to predict prognosis and immune response in bladder cancer
    Jia Chen
    Yu Guan
    Chun Li
    Hexi Du
    Chaozhao Liang
    Discover Oncology, 13
  • [32] Identification and validation of a novel cuproptosis-related lncRNA gene signature to predict prognosis and immune response in bladder cancer
    Chen, Jia
    Guan, Yu
    Li, Chun
    Du, Hexi
    Liang, Chaozhao
    DISCOVER ONCOLOGY, 2022, 13 (01)
  • [33] Identification of a cuproptosis-related lncRNA prognostic signature in lung adenocarcinoma
    Ran Chen
    Haichao Luo
    Qitian Chen
    Changying Wang
    Clinical and Translational Oncology, 2023, 25 : 1617 - 1628
  • [34] Identification of a cuproptosis-related lncRNA prognostic signature in lung adenocarcinoma
    Chen, Ran
    Luo, Haichao
    Chen, Qitian
    Wang, Changying
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2023, 25 (06): : 1617 - 1628
  • [35] A Novel Cuproptosis-Related Gene Signature Predicts Prognosis in Papillary Thyroid Carcinoma Patients
    Cao, Jun
    Zhang, Shijia
    Zhou, Kehui
    Mao, Xiaochun
    Zhao, Ming
    Shang, Jinbiao
    Lan, Xiabin
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2024,
  • [36] A novel cuproptosis-related gene signature for overall survival prediction in patients with hepatocellular carcinoma
    Yang, Fan
    Jiang, Shitao
    Liu, Yaoge
    Zhang, Ting
    Zhu, Chengpei
    Zhang, Lei
    Sang, Xinting
    Lu, Xin
    Wei, Jiaxin
    Deng, Kaige
    Zheng, Yongchang
    Xu, Yiyao
    HELIYON, 2022, 8 (11)
  • [37] A novel cuproptosis-related prognostic gene signature and validation of differential expression in hepatocellular carcinoma
    Li, Yaoting
    Zeng, Xuezhen
    FRONTIERS IN PHARMACOLOGY, 2023, 13
  • [38] A novel cuproptosis-related gene signature predicting overall survival in pediatric neuroblastoma patients
    Yang, Hu
    Yang, Jun
    Bian, Hongqiang
    Wang, Xin
    FRONTIERS IN PEDIATRICS, 2022, 10
  • [39] A novel cuproptosis-related lncRNA prognostic signature in thyroid cancer
    Liu, Lujia
    Xu, Jie
    Sun, Xifeng
    Zheng, Haitao
    BIOMARKERS IN MEDICINE, 2023, 17 (15) : 643 - 654
  • [40] Establishment and experimental validation of a novel cuproptosis-related gene signature for prognostic implication in cholangiocarcinoma
    Chen, Jialu
    Yu, Xiaopeng
    Tong, Huanjun
    Tang, Chengwei
    Tang, Zhaohui
    FRONTIERS IN ONCOLOGY, 2022, 12